Condition: Carcinoma, Squamous Cell · Oesophageal Cancer · Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
The primary objective of this study is to assess the feasibility of treatment with bintrafusp alfa combined with definitive chemoradiation (carboplatin, paclitaxel and radiation) in patients with squamous cell carcinoma of the esophagus or gastroesophageal junction.
This description comes directly from the study's public registry record.
Linde M Veen, MD · +31 20 4443312 · l.veen1@amsterdamumc.nl
Hanneke WM van Laarhoven, MD, PhD · +31 20 5665955 · h.vanlaarhoven@amsterdamumc.nl
Always discuss trial participation with your own doctor first.
| Academic Medical Center, Medical Oncology | Amsterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04481256